tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
PremiumThe FlyRocket Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
18d ago
Rocket Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Rocket Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
20d ago
Rocket Pharmaceuticals price target lowered to $19 from $51 at Scotiabank
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $19 from $51 at Scotiabank
20d ago
Rocket Pharmaceuticals price target lowered to $17 from $46 at Chardan
PremiumThe FlyRocket Pharmaceuticals price target lowered to $17 from $46 at Chardan
20d ago
Rocket Pharmaceuticals price target lowered to $8 from $30 at BMO Capital
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $8 from $30 at BMO Capital
20d ago
Rocket Pharmaceuticals price target lowered to $9 from $32 at BofA
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $9 from $32 at BofA
20d ago
Rocket Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyRocket Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
21d ago
Rocket Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Rocket Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley
21d ago
Rocket Pharmaceuticals downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Rocket Pharmaceuticals downgraded to Hold from Buy at TD Cowen
21d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100